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Cocaine strengthens excitatory synapses onto
midbrain dopamine neurons through the synaptic
delivery of GluR1-containing AMPA receptors. This
cocaine-evoked plasticity depends on NMDA recep-
tor activation, but its behavioral significance in the
context of addiction remains elusive. Here, we gener-
ated mice lacking the GluR1, GluR2, or NR1 receptor
subunits selectively in dopamine neurons. We report
that in midbrain slices of cocaine-treated mice,
synaptic transmission was no longer strengthened
when GluR1 or NR1 was abolished, while in the re-
spective mice the drug still induced normal condi-
tioned place preference and locomotor sensitization.
In contrast, extinction of drug-seeking behavior was
absent in mice lacking GluR1, while in the NR1
mutant mice reinstatement was abolished. In conclu-
sion, cocaine-evoked synaptic plasticity does not
mediate concurrent short-term behavioral effects of
the drug but may initiate adaptive changes eventually
leading to the persistence of drug-seeking behavior.
INTRODUCTION
A major hypothesis in the addiction field is that cocaine-induced
neuroadaptations in the mesocorticolimbic dopamine (DA) sys-
tem and associated limbic structures contribute to persistent
compulsive drug use and relapse (Kauer and Malenka, 2007;
Thomas et al., 2008). In particular, glutamatergic synapses on
DA neurons in the ventral tegmental area (VTA) undergo plastic
changes after cocaine administration (Saal et al., 2003; Ungless
et al., 2001). By increasing synaptic strength (Ungless et al.,
2001) and facilitating long-term potentiation (Liu et al., 2005),cocaine augments the responsiveness of DA neurons to gluta-
mate. Cocaine-induced synaptic strengthening in DA neurons in
the VTA is associated with changes in AMPA receptor (AMPAR)
subunit composition (Bellone and Lu¨scher, 2006). Thus, incorpo-
ration of GluR1 subunits, most likely by forming highly conductive,
calcium permeable GluR1 homomeric AMPARs, drives the drug-
induced synaptic strengthening, while the insertion of GluR2
containing receptors reverts it (Mameli et al., 2007). The synaptic
recruitment of GluR1 subunits and the resulting synaptic potenti-
ation requires the activation of NMDA receptors (NMDARs) (Dong
et al., 2004). Although synaptic strengthening of DA neurons by
a single (Ungless et al., 2001; Bellone and Lu¨scher, 2006) or
repeated (Borgland et al., 2004) cocaine injection may eventually
lead to enduring neuroplasticity (Thomas et al., 2008), its relation-
ship to drug-induced behavioral effects remains elusive.
Therefore, a fundamental but unresolved question is how
drug-induced synaptic changes in DA neurons relate to the de-
velopment of reinforcement and landmarks of addictive behavior
in rodents such as behavioral sensitization and drug-seeking be-
havior (Sanchis-Segura and Spanagel, 2006). While it is clear
that synaptic potentiation of excitatory synapses on DA neurons
of the VTA is too short-lasting (days) to serve as a neural sub-
strate for persistent addictive behavior, it may be essential for
early cocaine-induced behavioral responses and for triggering
long-term adaptations that underlie addiction (Lu¨scher and Bel-
lone, 2008; Thomas et al., 2008). In support of a behavioral link,
glutamate antagonists injected into the VTA reduce locomotor
sensitization (Carlezon and Nestler, 2002) and attenuate cocaine
reinforcement measured by conditioned place preference (CPP)
(Harris and Aston-Jones, 2003). Furthermore, cocaine exposure
increases GluR1 subunit expression in the VTA (Fitzgerald et al.,
1996; Churchill et al., 1999; Grignaschi et al., 2004; but see also
Lu et al., 2002), and virally mediated GluR1 upregulation in the
VTA increases drug-induced locomotor sensitization and CPP
(Carlezon et al., 1997). These results led to the hypothesis that
cocaine-induced locomotor sensitization and reinforcementNeuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc. 497
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depend on NMDARs in DA neurons of the VTA. However, direct
experimental evidence for the behavioral significance of the
cocaine-induced synaptic changes involving GluR1, GluR2,
and NMDARs in DA neurons is lacking.
RESULTS
Mice with Mutations Specific to DA Neurons
We used Cre/LoxP based conditional gene deletions in the
mouse to evaluate the role of individual glutamate receptor sub-
units in the cocaine-induced plasticity in DA neurons and the
Figure 1. Targeting of the Mutation to Dopaminergic
Cells
(A) Immunohistochemistry showing abundant Cre-positive
cells in the ventral tegmental area (VTA) and substantia nigra
pars compacta (SNpc) but not in surrounding areas.
(B) Micrograph from a Z/EGDATCre mouse, showing EGFP im-
munoreactivity, which indicates recombination. Recombina-
tion can be seen in structures known to harbor dopaminergic
cells while other structures show no signs of recombination.
(C) High-power micrograph from a ROSA26DATCre mouse.
Brown reaction product indicates immunoreactivity for
tyrosine hydroxylase, and blue reaction product indicates
presence of b-galactosidase, which is expressed only after
recombination. Note that recombination has occurred in all
TH-positive cells.
(D–U) Expression of GluR1, GluR2, and NR1 in dopaminergic
neurons of transgenic mice. (D–I) Representative coronal sec-
tions from the VTA showing immunofluorescence for GluR1
(D and G) and TH (E and H) in control (D–F) and GluR1DATCre
(G–I) mice, respectively. In sections from control mice,
GluR1 colocalize with TH, while GluR1 is only expressed in
TH-negative neurons (e.g., arrowheads) in GluR1DATCre mice.
(F and I) Overlay of the images in (D) and (E) and (G) and (H).
(J–O and P–U) Corresponding analysis for GluR2 and NR1 in
GluR2DATCre mice (M–O) with controls (J–L) and NR1DATCre
mice (S–U) with controls (P–R), respectively. Note that the de-
letion was efficient and specific in all cases.
functional importance of this plasticity for addic-
tion-related behavior. To achieve specific gene
deletion in DA neurons, we generated a mouse line
expressing the Cre-recombinase controlled by
the promoter of the dopamine transporter (DAT) (Par-
lato et al., 2006). The Cre construct, which is based
on a bacterial artificial chromosome (BAC) harbor-
ing the DAT gene, was integrated into the genome
by random insertion transgenesis. This approach
has the advantage that the endogenous DAT
gene is not compromised. In this specific line, it
has previously been shown that Cre expression
starts only postnatally and is preferentially localized
to midbrain DA neurons (Parlato et al., 2006). Thus,
hypothalamic DA neurons are not affected by re-
combination, likely due to the lower expression of
DAT in these neurons. Moreover, compensatory
mechanisms are not engaged during the prenatal
development (Parlato et al., 2006). As expected,
we found that Cre was expressed selectively in DA neurons of
the midbrain (Figure 1A). Cre recombination, which was visual-
ized by using the Z/EG and Rosa26-LacZ reporter lines, could
be induced in all midbrain DA neurons examined (Figures 1B
and 1C). However, we found no change in target abundance in
other structures of the brain (see Figure S1 available online).
To determine the role of GluR1 in cocaine-induced synaptic
plasticity, we generated mice lacking GluR1 in DA cells by cross-
ing a mouse line with floxed GluR1 with the DATCre line (GluR1fl/fl
3 DATCre, abbreviated GluR1DATCre mice). Since cocaine
triggers a plasticity that is expressed by the insertion of GluR2-
lacking AMPARs (Bellone and Lu¨scher, 2006) and induced498 Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc.
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Cocaine-Induced Synaptic Strengthening
(A) Representative traces from control mice of pharmacologically isolated
AMPAR-mediated EPSCs recorded at70, 0, and +40 mV and the mathemat-through NMDAR signaling (Dong et al., 2004), we also generated
mice lacking GluR2 (GluR2DATCre mice) and NR1 (NR1DATCre
mice) in DA neurons. As NR1 is an obligatory subunit, NMDAR
function should be abolished in NR1DATCre mice.
We first performed double immunofluorescence labeling for
GluR1, GluR2, or NR1 with tyrosine hydroxylase (TH), a marker
for DA neurons. In slices from control mice, GluR1, GluR2,
and NR1 were expressed in both TH-positive and TH-negative
neurons (Figures 1D–1F, 1J–1L, and 1P–1R) but were only
expressed in TH-negative neurons in the GluR1DATCre,
GluR2DATCre, and NR1DATCre mice, respectively (Figures 1G–1I,
1M–1O, and 1S–1U). This confirms the specific ablation of indi-
vidual glutamate receptor subunits in the transgenic mouse lines.
Cocaine-Induced Synaptic Strengthening Depends
on GluR1 and NR1 in DA Neurons
We next investigated the effects of our specific gene deletions on
basal synaptic transmission and cocaine-induced synaptic
strengthening by whole-cell patch recordings in acute slices of
the VTA. We measured AMPAR and NMDAR mediated excit-
atory postsynaptic currents (EPSCs) in voltage clamp conditions
at 70 mV and +40 mV in slices obtained from control mice in-
jected with a single dose of cocaine or saline (Figures 2A, 2B,
and S2). We then used these observations to calculate AMPA/
NMDA ratios by dividing AMPAR EPSCs collected at +40 mV
and 70 mV by NMDAR EPSCs measured at +40 mV (Figures
2C and S2). We also determined the rectification index RI
for AMPAR mediated responses (RI = EPSC 70 mV/EPSC
+40 mV). This was done in order to determine the contribution
of AMPARs lacking GluR2 since this type of AMPARs are calcium
permeable and show strongly rectifying synaptic responses,
i.e., currents are smaller at positive potentials compared to cur-
rents at symmetrical negative potentials.
In slices from saline-injected mice, we found normal values for
all parameters in GluR1DATCre mice (Figures 2D and 2F). In
ically subtracted NMDAR-mediated EPSC recorded at +40 mV and corre-
sponding I-V plots of AMPAR-EPSCs. Only the control group for the
GluR1DATCre mice is shown. The control groups for GluR2DATCre and NR1DATCre
mice are shown in Figure S2.
(B) Traces obtained using an identical protocol as above in slices from mice
exposed to a single injection of cocaine 24 hr prior to sacrifice.
(C) Bar graphs of AMPAR/NMDAR EPSC (A/N) ratio at +40 and 70 mV
and rectification index in same cells (Rectification index, RI = AMPAR
EPSC 70/AMPAR EPSC +40 mV).
(D–F) Corresponding experiments in GluR1DATCre mice: note that in GluR1
DATCre mice, A/N ratios and RI after cocaine injection remain unchanged.
(G–I) Corresponding experiments in GluR2DATCre mice: note that in cocaine-
treated GluR2DATCre mice, the A/N ratio when measured at 70 and +40 mV,
respectively, is higher compared to saline-injected mice.
(J and K) Traces and I-V plots of AMPAR-EPSCs in NR1DATCre mice. The A/N
cannot be calculated because NMDARs are absent.
(L) Example of an isolated AMPAR EPSC and corresponding NMDAR EPSC in
a non-DA neuron of a NR1DATCre mouse. Note that NMDAR EPSCs are present
in this neuron.
(M–O) Basal synaptic transmission is altered in DA neuron of the VTA from
NR1DATCre mice. DA neurons in the NR1DATCre mice showed an increased
frequency (M and N) but normal amplitudes (M and O) of spontaneous EPSC
recorded at 60 mV.
(P) RI in DA cells from NR1DATCre mice. Note that the RI is not increased in
NR1DATCre mice after cocaine injection. *p% 0.05, **p% 0.01.Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc. 499
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was strongly reduced precluding the calculation of RI (Figures
2G–2I), while when the AMPA/NMDA ratio was measured as
70 mV/+40 mV, there was no difference from saline-injected
controls (Figures 2I and S2). Taken together, these results reflect
a highly rectifying AMPAR population devoid of GluR2. In
NR1DATCre mice, the AMPA/NMDA ratio could not be calculated
since the NMDAR EPSCs were completely abolished (Figures 2J
and 2K) in DA neurons, albeit still present in neighboring GABA
neurons (Figure 2L). Strikingly, we found a higher occurrence
of spontaneous AMPAR-EPSCs (Figures 2M–2O) in NR1DATCre
mice, in line with an adaptive upregulation of AMPARs in the ab-
sence of NMDARs (Hall et al., 2007) through a process similar to
synaptic scaling observed in neuronal cultures (Turrigiano,
2007). Alternatively, the number of synaptic connections may
be higher in the NR1DATCre mice.
When ex vivo recordings were performed in slices from control
animals prepared 24 hr after a single exposure to cocaine (15 mg/
kg i.p.), we observed significant increases in the AMPAR/NMDAR
ratio as well as the RI in all control mouse lines (Figures 2C and S2;
p < 0.01), in line with previous reports (Bellone and Lu¨scher, 2006;
Ungless et al., 2001). We also examined whether repeated co-
caine administration increased the magnitude of the increase in
AMPAR-mediated synaptic transmission compared to a single
injection in control animals. Mice treated with seven injections
of cocaine showed a significantly larger RI (3.19 ± 0.68 versus
1.96 ± 0.18, n = 4, data not shown) 24 hr after the last injection
when compared to controls receiving multiple injections of saline.
The magnitude of this increase, however, was similar to that eli-
cited by a single injection of cocaine (Figure 2), which is in line
with a previous report in rats (Borgland et al. 2004).
Interestingly, in GluR1DATCre mice, the AMPAR/NMDAR ratio
and the RI did not differ between cocaine- and saline-injected
mice (Figure 2F). In GluR2DATCre the AMPAR/NMDAR ratio was
significantly larger in cocaine-treated mice compared to controls
(Figure 2I; p < 0.01). Both these observations confirm that the
expression of the cocaine-evoked plasticity is mediated by the
insertion of AMPARs containing GluR1 but not GluR2. Finally,
in NR1DATCre mice, no difference in rectification was observed
after cocaine treatment (Figure 2P), which supports the idea
that cocaine-induced plasticity at this synapse requires func-
tional NMDARs on DA neurons.
Collectively, these results demonstrate that on the functional
level the mutagenesis was efficient in DA neurons while not
affecting neighboring GABAergic neurons. Further, they show
that basal synaptic strength is unaffected in GluR1DATCre and
GluR2DATCre mice, while NR1DATCre mice show an increased re-
sponsiveness. Finally, the data provide genetic evidence that
GluR1, and probably also NMDARs, in DA cells are necessary
for the cocaine-induced synaptic strengthening and thus confirm
that GluR1DATCre and NR1DATCre mice are valid models for study-
ing the neurochemical and behavioral consequences of such
strengthening.
Normal Extracellular DA Release and Locomotor
Behavior in the Mutant Mice
The observed alterations in excitatory afferent transmission in
DA neurons in GluR1DATCre and NR1DATCre mice prompted us500 Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc.to study the release properties of DA neurons in these mutants.
To this end, we used microdialysis in freely moving mice. Guide
cannulas were implanted in the nucleus accumbens, and sam-
pling was performed 1 week later in the home cage. In controls,
the basal DA levels were 576 ± 148 pM. No significant differ-
ences were seen in comparison to GluR1DATCre (553 ± 152 pM)
and NR1DATCre mice (808 ± 365 pM), although a trend toward
higher values and more variability was seen in NR1DATCre mice
(Figure 3A). Since DA release in the nucleus accumbens strongly
influences locomotor activity, we also monitored home cage
activity for 48 hr before the microdialysis experiment started
(Figures 3C and 3F). In addition, we measured the exploration
behavior of these mice in an open-field arena (Figures 3D and
3G). Finally, further activity was monitored during the microdial-
ysis experiment (Figures 3E and 3H). Under all tested conditions
the mutant mice did not differ significantly from the control mice,
although NR1DATCre mice had a tendency to show enhanced
basal locomotor activity (Figures 3F and 3H).
An important feature of addictive drugs such as cocaine is the
increase of extracellular DA levels within the nucleus accum-
bens following acute application (Di Chiara and Imperato,
1988; Spanagel and Weiss, 1999; Lu¨scher and Ungless,
2006). After an i.p. administration of a 10 mg/kg dose of
cocaine, all genotypes responded with an approximately 5-fold
increase in DA levels (Figure 3B). Three hours later, all animals
were injected with a 20 mg/kg dose of cocaine leading to
a 10-fold increase in DA release. The changes in extracellular
DA after cocaine treatment were significant in all genotypes
(p < 0.0001), whereas there were no significant differences
between the genotypes for both doses (p = 0.40). In parallel,
on-line monitoring of cocaine-induced locomotor activity during
the microdialysis experiment (Figures 3E and 3H) did not reveal
any differences between the genotypes in response to the
10 mg/kg i.p. dose of cocaine. At the higher dose, activity
measurement was confounded by the occurrence of stereotypic
behavior in some animals.
Normal Cocaine-Induced Sensitization and Conditioned
Place Preference (CPP) in the Mutant Mice
To assess the short-term and long-term behavioral
consequences of GluR1, GluR2, and NR1 gene inactivation in
DA neurons, we used the mutant mice in various behavioral
tests that serve a models of core components of drug addic-
tion (Sanchis-Segura and Spanagel, 2006). First, we tested lo-
comotor activity following saline injection, which did not differ
between genotypes. Moreover, all animals similarly increased
their locomotor activity in response to an acute cocaine chal-
lenge (10 mg/kg; i.p.; Figures 4A–4C). These results are in
line with the normal DA levels seen in the mutant mice. Then
we tested the development of cocaine-induced behavioral sen-
sitization, a progressively escalating locomotor response to
a fixed drug dose (Sanchis-Segura and Spanagel, 2006).
Mice of all genotypes showed a progressive increase in co-
caine-induced activity, and no differences between genotypes
were observed (Figures 4A–4C). Our data suggest that GluR1-
driven synaptic strengthening in DA neuron and other cocaine-
evoked adaptations dependent on GluR1, GluR2, and/or NR1
Neuron
Synaptic Plasticity in Dopamine Neurons and Addictionin these cells do not play a role in cocaine-induced locomotor
sensitization.
Next, we tested the ability of these mice to acquire a CPP for
cocaine. In this test, which is used to measure reinforcement and
drug-seeking behavior (Tzschentke, 2007), mice are trained to
associate a given context with the drug, resulting in preference
for this environment compared to a saline-paired context. All ge-
notypes showed a robust CPP (Figures 5A–5C) for the cocaine-
paired compartment, identical to that of control mice. We found
no differences between genotypes in locomotor activity during
the CPP (Figure S3), and a pairwise correlation (Pearson’s index)
between the percental increase in locomotion and the CPP did
not covariate (r = 0.07, p = 0.60). In summary, GluR1DATCre,
GluR2DATCre, and NR1DATCre mice had CPP scores that were
indistinguishable from that exhibited by the appropriate control
mice.
Reduced Extinction of CPP in GluR1DATCre Mice
Drug addiction is characterized by persistent drug-seeking be-
havior (Sanchis-Segura and Spanagel, 2006). In order to assess
the persistence of cocaine-seeking behavior in our mutant mice,
we next studied the extinction of the CPP response. This was
done by saline injections in the previously drug-paired environ-
ment. As expected, control mice showed a robust, almost com-
plete, extinction of CPP after 16 extinction sessions (Figure 5A–
5C). Robust extinction was also observed in the GluR2DATCre
and NR1DATCre mice to a level identical to that of control mice. In-
terestingly, GluR1DATCre mice displayed no extinction of the CPP
(Figure 5A). Thus, there was a significant difference between ge-
notypes (control versus GluR1DATCre) in extinction of the CPP re-
sponse (p < 0.01), showing that GluR1 in DA neurons are essential
for extinction of cocaine-induced CPP. Locomotor activity during
extinction testing did not differ between genotypes (Figure S3).
Figure 3. Basal and Cocaine-Induced Ex-
tracellular Dopamine Levels and Locomotor
Activity in GluR1DATCre and NR1DATCre Mice
(A and B) Measurement of basal and cocaine-in-
duced extracellular dopamine levels in GluR1
DATCre, NR1DATCre mice and their respective con-
trols. (A) Basal levels of extracellular DA release
in pM measured in the nucleus accumbens of
GluR1DATCre (n = 6), NR1DATCre (n = 4), and control
mice (n = 8; since no differences occurred be-
tween both control groups, all control mice were
pooled together). These values correspond to
the averaged value of the first four samples col-
lected. (B) Percentage of increase of DA release
compared to baseline levels during 8 hr and fol-
lowing saline injection and successive cocaine
challenges (10 mg/kg and 20 mg/kg i.p.). The
changes after cocaine treatment were significant
in all genotypes (ANOVA for repeated-measures;
Treatment F23, 345 = 18.28, p < 0.0001) whereas
there were no statistically significant differences
between the genotypes for both doses (ANOVA
for repeated-measures; Treatment* Genotype
F46,345 = 1.04, p = 0.40).
(C–H) Measurement of basal and cocaine-induced
locomotor activity in GluR1DATCre, NR1DATCre
mice, and their respective controls. Home cage lo-
comotor activity was monitored over 48 hr for both
genotypes and appropriate control animals (n =
10–11 mice per genotype). Neither GluR1DATCre
nor NR1DATCre mice differed significantly from their
respective control mice. (D and G) Furthermore,
open field locomotor activity was assessed by
the distance traveled every 5 min for 30 min (n =
10–12 mice per genotype). Again, no significant
difference could be measured in GluR1DATCre
and in NR1DATCre mice compared to their respec-
tive controls. (E and H) Finally, locomotor activity
was assessed during the microdialysis experi-
ments. Both doses of cocaine enhanced activity
in controls and both genotypes (Newman-Keuls
post hoc for all genotypes, *p < 0.01 compared
to saline injection). However, at the 20 mg/kg
dose augmented stereotypic behavior was
observed in some animals.
All data presented are mean ± SEM.Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc. 501
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in DA Neurons
Another key feature of drug addiction is relapse (Sanchis-Segura
and Spanagel, 2006). Reinstatement of cocaine-seeking can be
triggered by drug-associated cues, stress, or drug re-exposure
(Shaham et al., 2003). Since control, GluR2DATCre, and NR1DATCre
Figure 4. Acute Cocaine-Induced Locomotion andCocaine-Induced
Behavioral Sensitization
Behavioral effects of cocaine in GluR1DATCre (n = 14), GluR2DATCre (n = 15),
NR1DATCre (n = 18), and control mice for each genotype (n = 14–19).
(A–C) Effects of acute and repeated cocaine injections on locomotor activity. A
single cocaine injection (10 mg/kg; i.p.) increased locomotion regardless of the
genotype (Coc-1) The development of sensitization was also independent of
the genotype, and it was expressed as a progressive increase of the locomo-
tion elicited by a fixed (10 mg/kg, i.p.) cocaine dose (Coc-4) (ANOVA for re-
peated-measures, Treatment, GluR1DATCre: F2,50 = 97.90, p < 0.001; GluR2
DATCre:
F2,46 = 33.52, p < 0.001; NR1
DATCre: F2,66 = 66.57, p < 0.001) . All data pre-
sented are mean levels ± SEM. Newman-Keuls post hoc for all genotypes:
*p < 0.01 compared to saline injection; #p < 0.01, compared to day 1.502 Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc.mice showed a normal extinction, we tested for reinstatement of
CPP in these lines, a test modeling relapse-like behavior (San-
chis-Segura and Spanagel, 2006; Shaham et al., 2003). As ex-
pected, a priming dose of cocaine completely reinstated CPP
Figure 5. Cocaine-Induced CPP, Extinction, and Reinstatement
The CPP score represents the time spent (seconds) in the cocaine-paired floor
minus the time spent in the saline-paired floor during the test day (test duration,
900 s). All animals exhibited a significant cocaine-induced CPP, and no geno-
type effect was observed (ANOVA for repeated-measures, GluR1DATCre: F1,50 =
0.3, p = 0.5; GluR2DATCre: F1,18 = 0.01, p < 0.9; NR1
DATCre: F1,31 = 2.49, p < 0.1).
Control, GluR2DATCre (A) and NR1DATCre (B) mice, but not GluR1DATCre (C) mice
displayed a significant reduction of the time spent on the cocaine-paired floor
after extinction training (Newman-Keuls post hoc, CPP response compared to
extinction in GluR1DATCre p = 0.8; GluR2DATCre p = 0.04; NR1DATCre p = 0.003).
Reinstatement of cocaine-seeking behavior was induced by a priming injec-
tion (7.5 mg/kg, i.p.) of cocaine. Whereas control mice and GluR2DATCre
showed a significant reinstatement of cocaine-seeking behavior, NR1DATCre
mice showed no reinstatement. All data are depicted as mean ± SEM.
*p < 0.01 compared to CPP; #p < 0.01 compared to extinction levels.
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NMDARs in DA neurons did not display reinstatement of co-
caine-seeking behavior (Figure 5C; p < 0.01). Again, GluR2DATCre
mice did not exhibit any obvious phenotype in this specific test
(Figure 5B). Since GluR1 mice did not show extinction, it was
not possible to test reinstatement. They maintained their prefer-
ence for the cocaine-paired compartment as expected. Notably,
locomotor behavior during reinstatement testing did not differ
between genotypes (Figure S3), showing that the mechanism
triggering reinstatement is distinct from the mechanisms main-
taining elevated locomotor activity in response to the drug.
These results show that NMDAR signaling in DA neurons is
critical for relapse-like behavior.
Inducible Mutation of NR1 in DA Neurons
As described above, we observed an upregulation of AMPAR-re-
sponses in the NR1DATCre line. We can therefore not rule out that
the absence of cocaine-evoked plasticity was due to occlusion
and that the basal enhanced AMPAR transmission could also in-
fluence the behavioral phenotype. To circumvent these adaptive
phenomena, we used a mouse line in which recombination
specific to DA neurons can be induced on demand. In this
DATCreERT2 mouse line, a Cre recombinase fused to a modified
ligand-binding domain of the estrogen receptor is expressed un-
der control of the DAT promoter (Figure 6A). Thus recombination
selectively in DA neurons can be triggered by repeated tamoxifen
administration (Feil et al., 1997; Erdmann et al., 2007). We gener-
ated NR1DATCreERT2 mice and injected them twice per day for 5
days with 1 mg tamoxifen starting at P15 to switch off NR1 synthe-
sis. We then allowed 8 days for the downregulation of endogenous
NMDARs, injected cocaine at day 9 and sacrificed the mice 24 hr
later. In slices from these mice, synaptic NMDAR responses were
absent in DA neurons but still present in neighboring non-DA neu-
rons, demonstrating the specificityof thedeletion (Figures6B–6E).
In tamoxifen-treated NR1DATCreERT2 mice, exposure to cocaine
did not affect the RI, and the current-voltage relationships of the
recorded neurons were linear reflecting transmission mediated
by GluR2-containing AMPARs (Figures 6B–6D). Taken together,
our results confirm that functional NMDARs are necessary for
the induction of the cocaine-evoked plasticity of glutamatergic
synapses onto DA neurons.
We next measured the CPP response to cocaine in
NR1DATCreERT2 mice. For this experiment, the mutation was
induced in 8-week-old male mice and CPP training was started
8 days later. Similar to NR1DATCre mice, tamoxifen-treated
NR1DATCreERT2 mutants showed a normal CPP response to
cocaine (Figure 7A). It is unlikely that the tamoxifen treatment
schedule applied here affects general behaviors such as loco-
motion, learning, and memory (Vogt et al., 2008). Nevertheless,
we also quantified the locomotor activity in the home cage and
in an open-field arena and did not observe any differences com-
pared to control animals that received vehicle injections (Figures
7B and 7C), showing that tamoxifen treatment per se had no im-
pact on the behavior in the CPP test. Finally, we tested extinction
and reinstatement of the CPP response in NR1DATCreERT2 and
control mice. Both genotypes showed normal extinction
(Figure 7A). A priming dose of cocaine completely reinstatedCPP in control mice (Figure 7A), while the mutants did not
reinstate cocaine-seeking behavior (Figure 7A; p < 0.01).
To determine whether NR1DATCreERT2 mice still showed the
scaling of the AMPAR-mediated responses, we performed elec-
trophysiological recordings in the same mice that were previ-
ously used for the behavioral test, which at that time were 80
days old (Figures 7D–7I). We found no difference in the frequency
nor in the amplitude of spontaneous EPSCs between the two ge-
notypes. We also determined the RI in DA neurons 48–72 hr after
the last cocaine injection and found linear current-voltage rela-
tionships in the NR1DATCreERT2 mice and significant rectification
in control mice (Figures 7D–7I).
Taken together, we conclude that NMDARs expressed on DA
neurons are required for the induction of the cocaine-induced
plasticity as well as reinstatement.
Figure 6. Generation of NR1DATCre Inducible Mice and Absence of
Cocaine-Evoked Plasticity in NR1DATCreERT2 Mice
(A) Schematic representation of the construct for the DATCreERT2 mouse line.
(B and C) EPSCs recorded at 70, 0, and +40 mV before and after APV appli-
cation and corresponding I-V plots of AMPAR-EPSCs from control and
NR1DATCreERT2 mice.
(D) Corresponding RI. Note that while increased in control mice, the RI is not
increased NR1DATCreERT2 mice 24 hr after cocaine injection. The A/N cannot
be calculated because NMDARs are absent.
(E) Example of an isolated AMPAR EPSC and corresponding NMDAR EPSC in
a nondopaminergic neuron of an NR1DATCreERT2 mouse. As expected, NMDAR
EPSCs are present in this neuron.
Error bars indicate SEM.Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc. 503
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cal Characterization of Adult NR1DATCreERT2 Mice
(A–C) Cocaine-induced CPP, extinction, reinstatement, and locomotor activity
in NR1DATCreERT2 mice. (A) The CPP score represents the time spent (s) in the
cocaine-paired floor minus the time spent in the saline-paired floor during the
test day (test duration, 900s). All control (n = 6) and NR1DATCreERT2 (n = 7) mice
exhibited a significant cocaine-induced CPP and displayed a significant
reduction of the time spent on the cocaine-paired chamber after extinction
training (compared to CPP). When the reinstatement of the CPP was
induced by a priming injection (7.5 mg/kg) of cocaine, only control but not
NR1DATCreERT2 mice showed reinstatement of cocaine-seeking behavior504 Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc.DISCUSSION
A major hypothesis in the etiology of addictive behavior points at
drug-induced plasticity within the mesocorticolimbic DA system
as one of the major causes of compulsive cocaine-seeking and
relapse behavior (Kauer and Malenka, 2007; Thomas et al.,
2008). In particular, it is suggested that cocaine strengthens
excitatory synapses on midbrain DA neurons, presumably by
NMDAR-dependent synaptic incorporation of GluR1-containing
AMPARs (Kauer and Malenka, 2007; Lu¨scher and Bellone, 2008).
The neurochemical and behavioral consequences of these drug-
induced molecular alterations are still unclear. Using conditional
knockout mice—lacking either GluR1, GluR2, or NR1 receptor
subunits selectively in DA neurons—we measured DA release
properties and cocaine-induced behaviors and correlated our
findings with the electrophysiological characterization of excit-
atory synaptic transmission onto DA neurons of the VTA. In sum-
mary, we show that mice lacking cocaine-induced synaptic
strengthening in DA neurons due to perturbed AMPAR plasticity
or NMDAR signaling exhibit normal basal and cocaine-induced
DA release properties. These mice also exhibit normal reinforce-
ment and behavioral sensitization to cocaine. However, we
found two alterations in the persistence of drug-seeking behav-
ior. First, a genetic deletion of the AMPAR GluR1 subunit within
DA neurons resulted in a specific deficit of extinction of cocaine-
induced reinforcement. Second, blocking NMDAR signaling in
DA neurons abolished reinstatement of cocaine-seeking behav-
ior in the CPP test, suggesting a critical role of this molecular
mechanism in relapse behavior. Reinstatement was absent
both in mice with a constitutive deletion of the NR1 subunit
selective to DA neurons, as well as in mice where NR1 was
removed in these neurons in adulthood.
The mouse models presented here have some advantages
compared to other approaches for gene inactivation. Most im-
portantly, we achieved highly specific targeting of glutamate re-
ceptor subunits in DA neurons. Such specificity is not achieved
by typical viral-mediated gene suppression methods, due to in-
fection of non-DA neurons. Our BAC-based Cre transgenesis
approach also has a clear advantage compared to previously re-
ported DATCre mice (Zhuang et al., 2005), since those mice have
only one allele for DAT, and it is well known that this causes
phenotypic effects that interfere with several DA-mediated be-
haviors (Giros et al., 1996; Spielewoy et al., 2000). In our DATCre
(compared to extinction). NR1DATCreERT2 and control mice were also moni-
tored for behavior in their home cage (B) and when they explored an open field
arena for 30 min (C). Home cage activity measured during 24 hours or the
distance traveled in the open field each 5 min intervals did not differ
between genotypes.
(D–I) NMDAR-mediated EPSPs in NR1DATCreERT2. (D and E) Traces recorded
at 70, 0, and +40 mV and the mathematically subtracted NMDAR-mediated
EPSC recorded at +40 mV and I-V plots of AMPAR-EPSCs obtained from con-
trol and NR1DATCreERT2 mice which underwent behavioral experiments. Mice
were sacrificed 48 hr after they were injected with cocaine during reinstate-
ment experiment. (F) Corresponding RI. Note that RI is increased in DA neu-
rons from control mice. (G) Sample traces showing spontaneous AMPAR
EPSCs from control and NR1DATCreERT2 mice. (H and I) Bar graph of spontane-
ous AMPAR EPSCs frequency and amplitude.
Error bars indicate SEM. #, *p % 0.05.
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precise conclusions regarding the gene of interest. Finally,
the tamoxifen-inducible system for selective mutagenesis in
DA neurons in the adult brain circumvents developmental adap-
tations, such as the scaling of spontaneous AMPAR-mediated
transmission.
Our electrophysiological data confirm the immunohistochem-
ical analysis showing that the mutagenesis was efficient in DA
neurons and that the AMPA/NMDA ratio is unaffected in
GluR1DATCre and GluR2DATCre mice, while NR1DATCre mice
show a scaling of spontaneous AMPAR transmission which
reflects an adaptation during synaptogenesis (Adesnik et al.,
2008). Finally, the electrophysiological data show that GluR1
and NMDARs in DA cells are necessary for the cocaine-induced
synaptic strengthening and thus confirm that GluR1DATCre and
NR1DATCre mice may be used to study the behavioral conse-
quences of such strengthening.
The behavioral characterization of mice lacking GluR1 in DA
neurons adds an important piece of information to the long-
standing debate on the functional role of GluR1-upregulation
and synaptic potentiation in these cells. It is known that GluR1
is upregulated in DA neurons in response to cocaine administra-
tion (Fitzgerald et al., 1996; Churchill et al., 1999; Grignaschi
et al., 2004; but see also Lu et al., 2002) and blockade of
AMPARs by intra-VTA administered antagonists reduces loco-
motor sensitization (Carlezon and Nestler, 2002). In an attempt
to link cocaine-evoked plasticity with behavior Dong et al.
(2004) tested knockout mice lacking GluR1 and found that loco-
motor sensitization did not differ from wild-type mice. However,
these mice show an increased basal locomotor activity and
a basal AMPA/NMDA ratio as high as after cocaine administra-
tion in wild-type mice (Dong et al., 2004). Moreover, since
GluR1 is absent in the entire brain, brain regions other than the
VTA may mediate the behavioral effects. The use of GluR1DATCre
mutants in the present study now demonstrates a clear
dissociation between synaptic potentiation in DA neurons and
locomotor sensitization.
The link between CPP and GluR1 is even more controversial.
In a study using GluR1 knockout mice, cocaine-induced CPP
was normal (Mead et al., 2005) while another group reported
a complete absence of CPP (Dong et al., 2004). An obvious dif-
ference between these studies is that Dong et al. (2004) used
a biased CPP protocol, whereas in Mead et al. (2005) and our
present study in GluR1DATCre mutants a nonbiased CPP protocol
was used, and different outcomes have been reported in several
other CPP studies when using biased versus nonbiased proto-
cols (Tzschentke, 2007). In order to further resolve this discrep-
ancy in the literature, we also tested if mice lacking GluR1 in the
whole brain can exhibit a normal CPP response to cocaine ad-
ministration in our nonbiased procedure. We found that GluR1
knockouts showed in fact a CPP response comparable to con-
trol mice (Figure S4), indicating that GluR1 is dispensable for
CPP under the conditions used in this study. This conclusion is
further supported by the results in our GluR1DATCre mice. They
have normal locomotor activity, normal levels of DA, and normal
AMPA/NMDA ratio under basal conditions but show no synaptic
potentiation in DA neurons in response to cocaine. The normal
CPP response in these mice shows that GluR1-upregulationand synaptic potentiation in DA neurons is not related to the
development of cocaine reinforcement.
NR1DATCre mutants also showed a normal CPP response to
cocaine and developed behavioral sensitization to the same de-
gree as control animals. At first sight, these findings might be
surprising in the light of previous studies using local VTA injec-
tions of NMDAR antagonists (Kalivas and Alesdatter, 1993;
Harris and Aston-Jones, 2003). Furthermore, in a very recent re-
port it was shown that cocaine-induced sensitization and CPP
are attenuated in NMDAR-deficient mice (Ramsey et al., 2008).
However, similar to the case with GluR1, our present study
differs fundamentally from these previous reports since we
targeted only DA neurons. These observations suggest that
NMDAR-dependent mechanisms in cells other than DA neurons
mediate sensitization and reinforcement. For example, in the
VTA, GABA and glutamate neurons are also present (Yamaguchi
et al., 2007). Moreover, expression of mutant NMDARs in D1
receptor-expressing neurons (i.e., non-DA neurons), prevents
cocaine sensitization and decreases cocaine preference
(Heusner and Palmiter, 2005).
One of our key findings is that a GluR1-dependent mechanism
in DA neurons is important for extinction of cocaine-seeking be-
havior. In line with this, a previous report has observed extinction
deficits in nonconditional GluR1 knockout mice following self-
administration of cocaine (Stephens and Mead, 2003).
Our second key finding is that NMDARs in DA neurons are
necessary for reinstatement of cocaine-seeking behavior. This
is in line with previous studies indicating that DA neurons projec-
ting to the medial prefrontal cortex are important for reinstate-
ment of cocaine self-administration by activating glutamatergic
neurons projecting to the nucleus accumbens (reviewed in
Schmidt et al., 2005). However, while the NR1DATCre mouse
line achieves selectivity for DA neurons in the midbrain, they
have altered baseline transmission, which may influence the be-
havior. To circumvent these limitations, we generated the
NR1DATCreERT2 mice where the NR1 subunit can be removed
once development is completed. Since our NR1DATCre and
NR1DATCreERT2 mice exhibit a normal CPP, we suggest that post-
learning reactivation of NMDARs is crucial for reinstatement of
drug-seeking behavior. In this respect, it has been shown previ-
ously that postlearning reactivation of NMDARs plays a more
general role in consolidation of memories (Wang et al., 2006).
It may be surprising that the behavioral phenotype of
GluR1DATCre mice differs from NR1DATCre mice—despite the ab-
sence of cocaine-evoked plasticity in both mouse lines. Since
the inducible NR1DATCreERT2 and the constitutive NR1DATCre line
showed similar behavioral alterations, we do not believe that
the scaling of AMPAR EPSC neurons observed in the NR1DATCre
line could explain this difference. Our data rather suggest that
extinction relies on a mechanism that requires GluR1 but is dis-
tinct from the NMDAR-dependent cocaine-evoked plasticity.
Since testing reinstatement is contingent to normal extinction,
it cannot be reliably done in the GluR1DATCre mice, but our model
would predict reinstatement to be absent in these mice. Alterna-
tively, since in the GluR1DATCre line GluR1 is constitutively absent
in all DA neurons, we cannot exclude that developmental adap-
tations or changes in DA neurons outside the VTA (e.g., substan-
tia nigra) influence this behavior.Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc. 505
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cocaine-induced synaptic strengthening in DA neurons seems
not to be related to cocaine-induced behavioral sensitization
and CPP. However, our data cannot exclude the possibility
that GluR1 and/or NR1 subunits in DA cells are important for sen-
sitization and reinforcement when using other experimental par-
adigms e.g., self-administration procedures or other addictive
drugs.
We further show that a genetic deletion of the AMPAR GluR1
subunit within DA neurons results in a specific deficit of extinc-
tion of cocaine-induced reinforcement. This finding provides
a new rationale in the treatment of cocaine addiction: the selec-
tive activation of the GluR1 subunit could potentially improve the
outcome of any given exposure therapy. In fact, it has recently
been shown that an AMPAR potentiator can facilitate extinction
learning for contextual fear memory (Zushida et al., 2007). There-
fore, the use of AMPAR potentiators may also facilitate extinction
processes related to cocaine taking behavior. Finally, we provide
evidence for a critical role of NMDAR signaling in DA neurons for
relapse behavior. Because of the temporal difference, the co-
caine-evoked plasticity can neither be the cellular correlate of
extinction nor reinstatement. However, synaptic plasticity in
the VTA could trigger adaptations in other parts of the brain.
Thus cocaine-evoked plasticity in the VTA could represent a first
step in a cascade of adaptive pathways that develop in parallel
and eventually lead to the persistent changes associated with
addiction (Lu¨scher and Bellone, 2008).
EXPERIMENTAL PROCEDURES
Mice
GluR1DATCre and GluR2DATCre mice were generated by crossing mice carrying
the DATCre transgene with GluR1fl/fl and GluR2fl/fl mice (Shimshek et al., 2006)
having loxP-flanked exons 11 of the Gria1 or Gria2(586R) alleles, respectively.
GluR1fl/fl mice were generated as described in Zamanillo et al. (1999).
NR1DATCre mice were generated by crossing mice carrying the DATCre trans-
gene with NR1fl/fl mice having exon 1118 of Grin1 flanked by loxP sites
(Niewoehner et al., 2007). The DATCre construct consists of an improved
Cre inserted at the transcriptional start of the DAT gene (Parlato et al., 2006).
DATCre mice have been characterized previously (Parlato et al., 2006). In order
to monitor the recombination, DATCre mice were also crossed with mice in
which the gene for LacZ has been introduced under control of the ROSA26
promoter but is interrupted by a loxP-flanked stop-cassette (Gt(ROSA)26-
Sortm1Sor), generating ROSA26DATCre mice. In addition, we crossed DATCre
mice with a second reporter line (Z/EG; Cg-Tg(CAG-Bgeo/GFP)21Lbe/J), in
which the expression of EGFP is triggered by Cre-mediated recombination.
All mice were backcrossed in C57BL6/N for at least six generations. For be-
havioral and electrophysiological experiments, GluR1DATCre (GluR1fl/fl; DAT-
Cre), GluR2DATCre, and NR1DATCre were used. As controls, fl/fl littermates not
carrying the Cre were used.
NR1DATCreERT2 mice were generated by crossing mice with an inducible Cre-
recombinase under the DAT-promoter with mice carrying floxed alleles for NR1.
The DATCreERT2 mice were generated by recombining a construct containing
an improved Cre-recombinase fused to a modified ligand binding domain of the
estrogen receptor (CreERT2) into a BAC containing the gene encoding DAT (the
same BAC as used for the DATCre line), using BAC recombineering. To induce
the mutation, 1 mg of tamoxifen was administered i.p. twice a day for 5 days,
according to previously published protocols (Erdmann et al., 2007).
Mice were housed individually, kept under a 12 hr light/12 hr dark conditions
(lights on 07–19) and fed ad libitum. All experimental procedures were
approved by the Committee on Animal Care and Use (Regierungspra¨sidium
Karlsruhe, License number 35-9185.81/G-153/05) and carried out in accor-506 Neuron 59, 497–508, August 14, 2008 ª2008 Elsevier Inc.dance with the local Animal Welfare Act and the European Communities
Council Directive of 24 November 1986 (86/609/EEC).
Histochemistry
Immunohistochemistry detecting the Cre-recombinase was performed using
a custom-made antiserum against Cre. The immunoreactivity was visualized
using an ABC, peroxidase, and DAB-based protocol (Parlato et al., 2006).
EGFP was detected with a polyclonal antibody (1:10000, Invitrogen,
A11122). X-gal histochemistry in combination with immunohistochemistry for
tyrosine hydroxylase was performed as previously described (Parlato et al.,
2006), with minor modifications. Thus mice were perfused with 4% PFA, and
brains were immediately transferred to 30% sucrose in PBS and incubated
overnight. Coronal sections were cut on a cryostat and incubated, free-float-
ing, in X-gal substrate overnight. Subsequently, immunohistochemistry was
performed using an anti-tyrosine hydroxylase antibody (1:2000; Chemicon).
For dual-labeling immunohistochemistry against glutamate receptors and
TH, affinity-purified polyclonal antibodies against GluR1 (AB1504), GluR2
(AB1768-25UG), and NR1 (AB9864) from Chemicon and a monoclonal anti-
body against TH (Calbiochem) were used. Animals were deeply anaesthetized
and transcardially perfused with saline followed by 4% paraformaldehyde in
0.1 M phosphate buffer (PB). Tissue blocks containing the area of DA neurons
were embedded in 4% agarose and sectioned at 60 mm with a microtome.
Sections were blocked in 10% normal goat serum (NGS) and subsequently in-
cubated in a mixture of primary antibodies for (1) GluR1 and TH, (2) GluR2 and
TH, or (3) NR1 and TH, in Tris-buffered saline (TBS) containing 2% NGS
overnight at 4C. For NR1 labeling, the sections were pretreated with 2 mg/ml
Pepsin in order to improve accessibility to the epitopes. After washes, sections
were further incubated in a mixture of secondary antibodies (anti-rabbit Alexa
488 for GluR1, GluR2, or NR1 and anti-mouse cyanine-derived fluorochrome
Cy3 for TH) made up in TBS for 2 hr at room temperature. Subsequently,
sections were washed, mounted, and coverslipped. Fluorescent signals
were examined using an epifluorescence microscope (Nikon).
Electrophysiology in Acute Slices
For the electrophysiological experiments, mice at postnatal days 18–80,
7–30 g bodyweight were used. Horizontal slices (250 mm thick) of the midbrain
were prepared in cooled artificial cerebrospinal fluid containing 119 mM NaCl,
2.5 mM KCL, 1.3 mM MgCl2, 2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM
NaHCO3 and 11 mM glucose, and bubbled with 95% O2 and 5% CO2.
Whole-cell voltage-clamp recording techniques were used (32C–34C,
2–3 ml min1, submerged slices) to measure the holding currents and synaptic
responses of DA neurons of the VTA, identified as the region medially to the
medial terminal nucleus of the accessory optical tract. DA neurons were
identified by the presence of a large hyperpolarization-activated (Ih) current
immediately after obtaining a whole-cell configuration. The internal solution
contained (mM):130 CsCl, 4 NaCl, 2 MgCl2, 1.1 EGTA, 5 HEPES, 2 Na2ATP,
5 sodium creatine-phosphate, 0.6 Na3GTP, and 0.1 spermine. Currents were
amplified, filtered at 5 kHz, and digitized at 20 kHz. The liquid junction potential
was small (3 mV), and therefore traces were not corrected. All experiments
except where noted were carried out in the presence of picrotoxin (100 mM)
and D,L-APV (100 mM). The holding potential was 50 mV, and the access
resistance was monitored by a hyperpolarizing step to 60 mV with each
sweep, every 10 s. Experiments were terminated if the access resistance var-
ied by more than 20%. Synaptic currents were evoked by stimuli (0.05–0.1 ms)
at 0.1 Hz through bipolar stainless steel electrodes positioned rostral to the
VTA. The NMDAR component was calculated as the difference between the
EPSCs measured in the absence and presence of D,L-APV (100 mM). The
AMPAR to NMDAR ratio was calculated by dividing the peak amplitudes.
The rectification index was calculated by dividing the amplitude of the
AMPAR-EPSC measured at 70 mV by the amplitude at +40 mV.
Microdialysis
Eight-month-old male GluR1DATCre, NR1DATCre mice and their respective con-
trols were used. Mice were mounted in a stereotactic device (Stoelting) under
isoflurane anesthesia and implanted unilaterally with a CMA7 guide cannula
(CMA Microdialysis AB) aiming at the nucleus accumbens (stereotaxic coordi-
nates, AP + 1.5 mm, L ± 0.8 mm, V 3.5 mm from bregma and dura surface).
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ment. After surgery, mice were placed back in their home cage equipped with
a Plexiglas cage extension (height, 20cm). Seven days after surgery, CMA7/1
microdialysis probes of 1 mm membrane length (CMA Microdialysis AB) were
slowly inserted and mice were connected to a single-channel liquid swivel and
a counterbalancing system (Instech Laboratories). Microdialysis probes were
perfused with sterile Ringer solution (Fresenius Kabi GmbH) at a flow rate of
1 ml/min using a PHD2000 microinfusion pump (Harvard Apparatus). After
overnight stabilization, the sampling period started from 8 hr to 16 hr. Micro-
dialysis samples were collected every 20 min in tubes containing 4 ml of
100 mM HClO4 for stabilization and stored at80C until HPLC analysis. After
the first four samples (baseline), the mice were injected with a saline solution.
Subsequently, 10 mg/kg and 20 mg/kg cocaine was administered (i.p.) to the
mice at 11 a.m. and 2 p.m., respectively. At the end of the experiment, the mice
were killed and the probe placements were checked histologically in 50 mm
brain sections. DA content in the dialysate samples was determined by high-
pressure liquid chromatography. Electrochemical detection was acquired
with the ALEXIS 100 cooled-micro LC-EC system (Antec Leyden bv) equipped
with a microbore VT-03 flow cell. The working potential of the cell was set at
400 mV and the oven temperature of the DECADE II at 35C. The mobile phase
of pH 6 contained 50 mM phosphoric acid, 400 mg/l OSA, 0.1 mM EDTA, 8 mM
KCl, and 15% methanol and was perfused with a flow rate of 200 ml/min. Du-
plicates of 4 ml aliquots of each sample were injected onto a reversed phase
column (C18, ALF-205 column, 50 3 2.1 mm ID, 3 mm; Axel Semrau GmbH
& Co. KG), and the DA content was determined using the area under
the peak with an external standard curve as a reference. Detection limits for
DA was 50 pM with a signal-to-noise ratio of 2. All data were analyzed with
two-way ANOVAs for repeated-measures. Data presented are mean ± SEM.
Behavioral Procedures
Animals (12–24 weeks) were treated i.p. with a standard dose of 10 mg/kg of
cocaine (Sigma), except for the reinstatement, where 7.5 mg/kg was used.
This dose of cocaine dose was chosen because it proved to be most reliable
in a previous study involving cocaine CPP in complete GluR1 and GluR2
knockout mice (Mead et al., 2005). Behavioral experiments started 1 week
after the arrival of the animals in the laboratory environment and were always
conducted between ZT2-6.
The procedure of acquisition, extinction, and reinstatement of cocaine-
induced CPP was adapted from the original description (Itzhak and Martin,
2002), and other effects of cocaine (acute locomotion and locomotor sensiti-
zation) were also measured. CPP was conducted in six gray acrylic chambers
(32 cm long3 16 cm wide3 22 cm high) as described (Abarca et al., 2002). The
whole procedure consisted of six phases: preconditioning (1 session), condi-
tioning (8 sessions), preference test (1 session), extinction pairings (16 ses-
sions), extinction tests, and the reinstatement test (1 session). All sessions
were monitored by a video-tracking system (Ethovision 2.0, Noldus), which en-
abled us to determine locomotion and spatial placement of each mouse each
0.2 s across the whole session.
At day 1 (preconditioning session; duration, 30 min) all subjects were placed
inside the conditioning chamber with a distinctive floor (a smooth plastic sur-
face covered with soft tissue paper). The conditioning phase started the next
day and followed an unbiased Pavlovian conditioning procedure in which mice
belonging to the different genotype-based groups were randomly assigned to
one of two experimental conditions (CS+, Rod+ or Hole+; or CS, Rod or
Hole). During the conditioning phase (session length: 30 min) subjects had
access to the entire apparatus but only one floor type (Rod or Hole) was pre-
sented. On CS+ trials, each mouse received an injection of cocaine (10 mg/kg;
i.p.), whereas in the CS trials, animals were injected with equal volumes of sa-
line. Immediately after injection, mice were placed in the conditioning appara-
tus containing the corresponding floor. The order of the CS+ and CS trials was
counterbalanced among animals, and each floor were designed as CS+ or CS
for half of the animals of each genotype-based group. The effects of an acute
cocaine challenge on locomotion were assessed by comparing the distance
traveled (cm/30 min) during the first CS+ and the first CS trials, and co-
caine-induced behavioral sensitization was assessed by analyzing the
changes in locomotion across the four CS+ trials. The preference test took
place 24 hr after the last conditioning trial. To conduct this test, the floorwas divided with half Rod and half Hole, and mice were placed in the center
of the chamber without any previous injection. The relative position (left versus
right) of each floor was counterbalanced. Preference test duration was 15 min.
The primary dependent variable of this test was the amount of time spent on
CS+ and CS floor during the whole 15 min test session, although locomotion
was also measured. Extinction consisted of a total of 16 daily sessions in which
both floors were paired with saline. The extinction test on day 16 was identical
to the preference test described above. On the following day, a priming injec-
tion (7.5 mg/kg) was used to reinstate the extinguished CPP (Itzhak and Martin,
2002). CPP reinstatement was assessed in a test identical to the first prefer-
ence test described above. All data are presented as means ± the standard
error of the mean (SEM), and a significance level of p % 0.01 was used.
Most of the statistical treatment of the data was conducted using one- or
two-way ANOVA, with a repeated-measures factor when necessary, followed
by Newman-Keuls post hoc tests, when appropriate.
SUPPLEMENTAL DATA
The Supplemental Data include four figures and can be found with this article
online at http://www.neuron.org/cgi/content/full/59/3/497/DC1/.
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